Evaluation of Unintentional Weight Loss

Initial Assessment and Indications for CT Scanning

In patients with significant unintentional weight loss, a contrast-enhanced CT abdomen/pelvis is recommended if weight loss is greater than 5% of body weight in 6-12 months, plus any of the following: age over 60 years, additional symptoms (especially GI symptoms), abnormal physical examination findings, laboratory abnormalities (especially elevated white blood cell count), or elevated tumor markers, as suggested by the American College of Radiology 1

CT scanning in unintentional weight loss yields a diagnosis in approximately 49% of cases, indicating good diagnostic value, although the exact percentage may vary 1
The diagnostic yield of CT for unexplained weight loss is approximately 12.8-33.5%, with the most common causes being non-malignant gastrointestinal conditions and cancer, as stated by the World Journal of Emergency Surgery 1

In patients with a history of bariatric surgery, special attention to anatomical landmarks is essential for accurate interpretation of CT scans, as stated by the World Journal of Emergency Surgery 1

Alternative initial imaging modalities, such as MRI or ultrasound, should be considered in patients with contraindications to IV contrast, pregnancy, or younger patients (<60 years) with isolated weight loss and no other concerning features, as recommended by the American College of Radiology 1

Contrast-enhanced CT is essential for evaluating suspected vascular pathology, including visualizing vessel walls, lumen, and potential complications, in patients with suspected vascular disease, as suggested by the American College of Radiology 2
The American College of Radiology recommends CT with IV contrast as the reference standard for abdominal aortic aneurysm (AAA) diagnosis and management decision-making, particularly for evaluating the extent of the aneurysm and planning treatment 3
Contrast-enhanced CT is the imaging examination of choice for suspected diverticulitis, and helps differentiate tumor from surrounding tissues, enabling evaluation of tumor vascularity and enhancement patterns, as recommended by the American College of Radiology 4, 5

Severe contrast allergy and significant renal insufficiency are contraindications for contrast-enhanced CT, while the diagnostic question can be adequately answered without contrast in some cases, as suggested by the American College of Radiology 4, 6
The American College of Radiology recommends avoiding contrast-enhanced CT in patients with severe contrast allergy, unless appropriate premedication and emergency measures are available, due to the risk of anaphylaxis, and using contrast only when benefits clearly outweigh risks in pregnant patients, considering alternative imaging modalities like MRI or ultrasound 6

Oral contrast may improve sensitivity for pancreatic injuries, particularly in cases of blunt abdominal trauma, and is valuable in assessing the gastrointestinal tract, specifically to evaluate for bowel obstruction, inflammatory conditions, fistulas, and masses, as suggested by the American College of Radiology 7, 8
Oral contrast opacifies the bowel lumen, allowing for better assessment of small bowel obstruction, including transition points and degree of obstruction, as well as inflammatory bowel disease, fistula formation, and bowel masses or neoplasms, as suggested by the American College of Radiology 8
The American College of Radiology recommends avoiding oral contrast in high-grade small bowel obstructions, as it can delay diagnosis, increase patient discomfort, and limit the ability to detect abnormal bowel wall enhancement in cases of ischemia, and considering the risk of aspiration when evaluating patients for oral contrast administration, particularly in trauma cases 5, 8, 7

CT enterography, using large volumes of neutral contrast, may be preferred for detailed small bowel assessment in stable patients, as suggested by the American College of Radiology 9
Oral contrast is particularly valuable in low-grade or intermittent small bowel obstruction, helping to identify subtle transition points and assess for partial vs. complete obstruction by evaluating contrast progression, as suggested by the American College of Radiology 8

Contrast administration should be timed to coincide with the appropriate phase of enhancement based on the clinical question, with arterial phase for vascular abnormalities and hypervascular tumors, portal venous phase for most abdominal imaging, and delayed phase for urinary tract and biliary evaluation, as suggested by the American College of Radiology 4, 3
The arterial phase (15-30 seconds post-injection) is best for vascular abnormalities and hypervascular tumors, while the portal venous phase (60-90 seconds post-injection) is optimal for most abdominal imaging, and the delayed phase (3-5 minutes post-injection) is useful for urinary tract and biliary evaluation, although the specific timing may vary depending on the patient and the diagnostic question, as suggested by the American College of Radiology 3